18,587 articles
Jeff Iliff
Jeff Iliff is an American neuroscientist who led the team that discovered the glymphatic system, the brain's waste-clearance pathway, and now researches it at the University of Washington.
Jeff Lichtman
Jeff W. Lichtman is an American neuroscientist and Harvard professor known for the Brainbow method of labeling neurons and for connectomics, mapping neural connections in the mammalian brain.
Jeff Schell
Jozef Stefaan "Jeff" Schell (1935–2003) was a Belgian molecular biologist who pioneered Agrobacterium-mediated plant transformation, enabling the first transgenic plants and co-founding Plant Genetic Systems in Ghent in 1982.
Jeff Settleman
Jeff Settleman is an American cancer biologist who has been Chief Scientific Officer for Oncology R&D at Pfizer since 2019, after leading oncology research at Calico and Genentech.
Jeff W.M. Bulte
Jeff W.M. Bulte is a Johns Hopkins professor and molecular imaging researcher who pioneered labeling cells with iron oxide nanoparticles so they can be tracked by MRI.
Jeffery D. Molkentin
Jeffery D. Molkentin is an American molecular cardiologist who directs molecular cardiovascular biology at Cincinnati Children's Hospital and defined the calcineurin-NFAT pathway in cardiac hypertrophy.
Jeffery F. Miller
Jeffery F. Miller is an American microbiologist at UCLA who studies bacterial pathogenesis and discovered diversity-generating retroelements, and was elected to the National Academy of Sciences in 2015.
Jeffery K. Taubenberger
Jeffery K. Taubenberger is an American virologist and pathologist who led the sequencing of the 1918 pandemic influenza virus genome and served as acting director of NIAID from 2025.
Jeffery L. Barker
Jeffery L. Barker is a cellular neuroscientist at the National Institutes of Health known for single-channel studies of how barbiturates enhance and convulsants block GABA-mediated inhibition.
Jeffery L. Dangl
Jeffery L. Dangl, born 1957, is an American plant geneticist at the University of North Carolina at Chapel Hill known for his work on the plant immune system.
Jeffery M. Stadel
Jeffery M. Stadel is a clinical pharmacology researcher who, as a fellow in Robert Lefkowitz's Duke laboratory, co-authored the 1980 paper proposing the ternary complex model of GPCR activation.
Jeffery M. Vance
Jeffery M. Vance is an American neurogeneticist at the University of Miami known for showing that the APOE-ε4 allele is a major Alzheimer's risk factor.
Jeffery S. Cox
Jeffery S. Cox, born 1967, is a microbiologist and professor at UC Berkeley known for work on tuberculosis, including the ESX-1 secretion system of Mycobacterium tuberculosis.
Jeffery W. Kelly
Jeffery W. Kelly, born in 1960, is an American chemical biologist at Scripps Research whose lab discovered tafamidis, the first drug to slow a human amyloid disease.
Jeffrey A. Bluestone
Jeffrey A. Bluestone is an American immunologist and UCSF professor whose research on T-cell tolerance produced CTLA4Ig and teplizumab, the first drug approved to delay type 1 diabetes.
Jeffrey A. Cohen
Jeffrey A. Cohen is an American neurologist specializing in multiple sclerosis at the Cleveland Clinic's Mellen Center, known for leading the 2010 TRANSFORMS trial of oral fingolimod.
Jeffrey A. Engelman
Jeffrey A. Engelman is an American oncologist who studied resistance to targeted kinase inhibitors in lung cancer at Mass General, then joined Novartis in 2016 and co-founded Treeline Biosciences.
Jeffrey A. Fessler
Jeffrey A. Fessler is an electrical engineer at the University of Michigan known for statistical image reconstruction algorithms for CT, MRI, and PET, including the 1994 SAGE algorithm.
Jeffrey A. Frelinger
Jeffrey A. Frelinger is an American immunologist at the University of Arizona known for MHC research and as president of the American Association of Immunologists.
Jeffrey A. Meyerhardt
Jeffrey A. Meyerhardt is an American gastrointestinal medical oncologist at Dana-Farber Cancer Institute in Boston, where he leads colorectal cancer research and national phase 3 clinical trials.
Jeffrey A. Norton
Jeffrey A. Norton is an American surgical oncologist who led surgical oncology at Stanford from 2003 to 2020 and established surgery as a cure for Zollinger–Ellison syndrome.
Jeffrey A. Towbin
Jeffrey A. Towbin is an American pediatric cardiologist known for gene discovery in the cardiomyopathies and the "final common pathway" hypothesis of heart muscle disease.
Jeffrey A. Whitsett
Jeffrey A. Whitsett is an American physician-scientist at Cincinnati Children's Hospital Medical Center whose work on surfactant proteins helped make surfactant replacement therapy routine for premature infants.
Jeffrey Aronson
Jeffrey Kevin Aronson, born 1947, is a British clinical pharmacologist at Oxford known for work on adverse drug reactions and editing Meyler's Side Effects of Drugs.
Jeffrey Benovic
Jeffrey L. Benovic is an American biochemist at Thomas Jefferson University in Philadelphia, trained under Robert Lefkowitz, known for discovering GRK2 and β-arrestin's role in receptor endocytosis.
Jeffrey Borer
Jeffrey S. Borer (1945–2026) was an American cardiologist who developed stress radionuclide cineangiography, the first noninvasive technique for assessing cardiac function during exercise, and studied valve replacement timing in aortic regurgitation.
Jeffrey Brent
Jeffrey Brent is an American emergency physician and medical toxicologist at the University of Colorado, known for clinical trials of fomepizole for toxic alcohol poisoning.
Jeffrey C Magee
Jeffrey C Magee is a cellular and synaptic neuroscientist and HHMI Investigator at Baylor College of Medicine, known for discovering behavioral timescale synaptic plasticity in the hippocampus.
Jeffrey C. Barrett
Jeffrey C. Barrett is a statistical geneticist known for the Haploview software, inflammatory bowel disease genetics, and the Deciphering Developmental Disorders study of rare disease.
Jeffrey C. Hall
Jeffrey C. Hall is an American geneticist at Brandeis University who shared the 2017 Nobel Prize in Physiology or Medicine for discovering circadian clock mechanisms.